426 related articles for article (PubMed ID: 28917373)
41. Efficacy and safety of exogenous ketone bodies for preventive treatment of migraine: A study protocol for a single-centred, randomised, placebo-controlled, double-blind crossover trial.
Gross E; Putananickal N; Orsini AL; Schmidt S; Vogt DR; Cichon S; Sandor P; Fischer D
Trials; 2019 Jan; 20(1):61. PubMed ID: 30654835
[TBL] [Abstract][Full Text] [Related]
42. A herbal remedy, Hyben Vital (stand. powder of a subspecies of Rosa canina fruits), reduces pain and improves general wellbeing in patients with osteoarthritis--a double-blind, placebo-controlled, randomised trial.
Rein E; Kharazmi A; Winther K
Phytomedicine; 2004 Jul; 11(5):383-91. PubMed ID: 15330493
[TBL] [Abstract][Full Text] [Related]
43. Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies.
Silberstein SD; Armellino JJ; Hoffman HD; Battikha JP; Hamelsky SW; Stewart WF; Lipton RB
Clin Ther; 1999 Mar; 21(3):475-91. PubMed ID: 10321417
[TBL] [Abstract][Full Text] [Related]
44. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
45. The effect of Rosa damascena essential oil on the amygdala electrical kindling seizures in rat.
Ramezani R; Moghimi A; Rakhshandeh H; Ejtehadi H; Kheirabadi M
Pak J Biol Sci; 2008 Mar; 11(5):746-51. PubMed ID: 18819571
[TBL] [Abstract][Full Text] [Related]
46. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
Freitag F; Smith T; Mathew N; Rupnow M; Greenberg S; Mao L; Finlayson G; Wright P; Biondi D;
Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700
[TBL] [Abstract][Full Text] [Related]
47. Rosa damascena together with brown sugar mitigate functional constipation in children over 12 months old: A double-blind randomized controlled trial.
Imanieh MH; Honar N; Mohagheghzadeh A; Haghighat M; Dehghani SM; Mosleh G; Ataollahi M; Safarpour H; Darban B; Karbasian F; Safarpour AR; Hassani AH; Avazpour A
J Ethnopharmacol; 2022 Nov; 298():115582. PubMed ID: 35963416
[TBL] [Abstract][Full Text] [Related]
48. [Treatment of migraine attacks: combination of dihydroergotamine tartrate and paracetamol in comparison with individual drugs and placebo].
Hoernecke R; Doenicke A
Med Klin (Munich); 1993 Nov; 88(11):642-8. PubMed ID: 8295604
[TBL] [Abstract][Full Text] [Related]
49. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of the effect of aromatherapy with Rosa damascena Mill. on postoperative pain intensity in hospitalized children in selected hospitals affiliated to Isfahan University of Medical Sciences in 2013: A randomized clinical trial.
Marofi M; Sirousfard M; Moeini M; Ghanadi A
Iran J Nurs Midwifery Res; 2015; 20(2):247-54. PubMed ID: 25878704
[TBL] [Abstract][Full Text] [Related]
51. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
[TBL] [Abstract][Full Text] [Related]
52. Potential effect and mechanism of action of topical chamomile (Matricaria chammomila L.) oil on migraine headache: A medical hypothesis.
Zargaran A; Borhani-Haghighi A; Faridi P; Daneshamouz S; Kordafshari G; Mohagheghzadeh A
Med Hypotheses; 2014 Nov; 83(5):566-9. PubMed ID: 25238714
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and safety of 400 and 800 mg etodolac vs. 1,000 mg paracetamol in acute treatment of migraine: a randomized, double-blind, crossover, multicenter, phase III clinical trial.
Öztürk V; Ertaş M; Baykan B; Sirin H; Özge A;
Pain Pract; 2013 Mar; 13(3):191-7. PubMed ID: 22730906
[TBL] [Abstract][Full Text] [Related]
54. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
55. Rosa Damascena oil improved methadone-related sexual dysfunction in females with opioid use disorder under methadone maintenance therapy - results from a double-blind, randomized, and placebo-controlled trial.
Farnia V; Tatari F; Alikhani M; Yazdchi K; Taghizadeh M; Sadeghi Bahmani D; Karbasizadeh H; Holsboer-Trachsler E; Brand S
J Psychiatr Res; 2017 Dec; 95():260-268. PubMed ID: 28923720
[TBL] [Abstract][Full Text] [Related]
56. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
Dodick DW; Turkel CC; DeGryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF;
Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
[TBL] [Abstract][Full Text] [Related]
57. Alniditan in the acute treatment of migraine attacks: a subcutaneous dose-finding study. Subcutaneous Alniditan Study Group.
Goldstein J; Dahlöf CG; Diener HC; Olesen J; Schellens R; Senard JM; Simard D; Steiner TJ
Cephalalgia; 1996 Nov; 16(7):497-502. PubMed ID: 8933995
[TBL] [Abstract][Full Text] [Related]
58. A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.
Aurora SK; Rozen TD; Kori SH; Shrewsbury SB
Headache; 2009 Jun; 49(6):826-37. PubMed ID: 19545249
[TBL] [Abstract][Full Text] [Related]
59. Effect of rose oil on Gastroesophageal Reflux Disease in comparison with omeprazole: A double-blind controlled trial.
Adel Mehraban MS; Shirzad M; Ahmadian-Attari MM; Shakeri R; Taghizadeh Kashani LM; Tabarrai M; Shirbeigi L
Complement Ther Clin Pract; 2021 May; 43():101361. PubMed ID: 33735635
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
